Patient Selection for Protected Percutaneous Coronary Intervention: Who Benefits the Most?

Interv Cardiol Clin. 2022 Oct;11(4):455-464. doi: 10.1016/j.iccl.2022.07.001.

Abstract

The evolution of percutaneous coronary intervention (PCI) enables a complete revascularization of complex coronary lesions. However, simultaneously, patients are presenting nowadays with higher rates of comorbidities, which may lead to a lower physiologic tolerance for complex PCI. To avoid hemodynamic instability during PCI and achieve safe complete revascularization, protected PCI using mechanical circulatory support devices has been developed. However, which patients would benefit from the protected PCI is still in debate. Hence, this review provides practical approaches for the selection of patients by outlining current clinical data assessing utility of protected PCI in high-risk patients.

Keywords: High-risk-PCI; IABP; LAAD; MCS devices; Protected PCI; VA-ECMO; pLVAD.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Heart-Assist Devices* / adverse effects
  • Humans
  • Patient Selection
  • Percutaneous Coronary Intervention* / adverse effects